General Practice · Delray Beach, FL
NPI
1174548226
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
100 E Linton Blvd, Suite 203a
Delray Beach, FL, 33483
Phone (561) 265-4969
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,933
28 services
Medicare patients, 2024
19
Average age 68
Drug cost, 2024
$2.7M
3,194 prescriptions
Company payments, 2024
$20.27
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Paris was code 99213 (office e&m - established), 17 times for 11 patients. In total Mark Paris billed 28 services in 2 codes, and Medicare paid $1,933.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 17 | 11 | $64.25 | $1,092 |
| 99214 Office E&M - Established | Office | 11 | 11 | $76.40 | $840 |
By year: 2022 $489 for 13 services; 2023 $2,244 for 32 services; 2024 $1,933 for 28 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark Paris prescribed most often to Medicare patients was Descovy (Emtricitabine/Tenofov Alafenam), with 395 prescriptions and refills. In total Mark Paris wrote 3,194 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Descovy Emtricitabine/Tenofov Alafenam | 395 | 395 | 30 | $847K |
| Tivicay Dolutegravir Sodium | 312 | 312 | 23 | $685K |
| Amlodipine Besylate Generic | 146 | 209 | 27 | $449 |
| Atorvastatin Calcium Generic | 139 | 222 | 24 | $573 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 127 | 155 | 15 | $2,391 |
| Prezcobix Darunavir/Cobicistat | 116 | 116 | Under 11 | $271K |
| Gabapentin Generic | 91 | 119 | 18 | $1,676 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 89 | 89 | Under 11 | $329K |
| Metformin Hcl Generic | 77 | 101 | 12 | $228 |
| Rosuvastatin Calcium Generic | 56 | 125 | 16 | $529 |
| Omeprazole Generic | 55 | 59 | Under 11 | $593 |
| Eliquis Apixaban | 53 | 57 | Under 11 | $33K |
| Fluticasone Propionate Generic | 51 | 65 | 15 | $453 |
| Lisinopril Generic | 49 | 79 | Under 11 | $128 |
| Metoprolol Succinate Generic | 49 | 51 | Under 11 | $762 |
Brand drugs: 1,345 claims; generic drugs: 1,849 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Mark Paris $20.27 ($20.27 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $20.27.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $20.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.